期刊文献+

前列腺增生患者膀胱顺应性相关尿流动力学指标的影响因素 被引量:9

Influencing factors of urodynamic bladder compliance index in patients with benign prostate hyperplasia
下载PDF
导出
摘要 目的探讨尿流动力学检查过程中,前列腺增生(BPH)患者顺应性检测数据的影响因素,通过修正顺应性标签的设置等方法,更客观真实地反应患者膀胱功能状况。方法通过对193例BPH患者(合并膀胱过度活动的患者89例以及不合并膀胱过度活动的患者104例)尿流动力学检查过程中使用技术的变化,分析引起检测结果数据异常的原因,并对检测结果作出相应的调整。结果对于合并OAB的患者,尿流动力学检查设备自动生成的膀胱顺应性比值(BC值)误差发生率较高;对于低顺应性患者,灌注速度对BC值有明显干扰;对于合并重度OAB的患者,尿动力学检查数据重复性差。结论对于合并OAB的BPH患者,应注意低速灌注,修正顺应性标签的设置使尿流动力学检测结果更客观真实。 Objective To investigate the influencing factors of bladder compliance (BC) in urodynamic test for patients with benign prostatic hyperplasia (BPH), in order to improve urodynamic examination technics. Methods Technics used in the urodynamic examination for 193 patients with BPH and causes of abnormal data were analyzed. Results The generated BC values of urodynamic examination equipment automatically had higher error rate. The perfusion speed had an obvious influ- ence on test results. For severe overactive bladder (OAB), the checked data of two examinations over the same period had great difference. Conclusion For BPH patients complicated with OVB, the speed of perfusion should be slow. Attention should be paid to compliance label setting in order to obtain accurate examination results.
出处 《现代泌尿外科杂志》 CAS 2014年第8期525-527,共3页 Journal of Modern Urology
关键词 前列腺增生 顺应性 尿流动力学 膀胱过渡活动 逼尿肌压力 benign prostate hyperplasia compliance urodynamic overactive bladder detrusor pressure
  • 相关文献

参考文献10

二级参考文献79

共引文献56

同被引文献84

  • 1吴绍文,唐云峰,李强,李洪波,温秀琳.非那雄胺与多沙唑嗪联用对鼠前列腺增生模型的影响[J].河北医学,2006,12(6):507-510. 被引量:5
  • 2WHITE, WILLIAM J. The results of double castration in hy pertrophyof the prostate[J]. AnnSurg, 2008, 22(1):1-80.
  • 3RITTMASTER R, HAHN R P, SHANNON J, et al. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer[J]. Ritorno AI Numero, 2008, 72(4):808 -812.
  • 4MCCONNEI.L J D, BRUSKEWITZ R, WALSH P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hy- perplasia[J]. New EnglandJ Med, 1998, 338(9) :557 -563.
  • 5JEONG Y B, KWON K S, KIM S D, et al. Effect of discontinu- ation of 5a-Reductase inhibitors on prostate volume and syrup toms in men with BPH:A prospective study[J]. Urology, 2009, 73(4) :802-806.
  • 6TAMMELA T L, KONTTURI M J. Long-term effects of finas teride on invasive urodynamics and symptoms in treatment of pa-tients with bladder outflow obstruction due to benign prostatic hyperplasia[J]. J Urology, 1995, 154(4) :1466-1469.
  • 7JOHNSON T M, BURROWS P K, KUSEK J W, et al. The effect of doxazosin, finasteride and combination therapy on noc- turia in men with benign prostatic hyperplasia[J]. J Urol, 2007, 178(5) :2045-2051.
  • 8EKMAN P. Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years, follow-up of the scandinavi- an open-extension study. The Scandinavian Finasteride Study Group[J]. Eur Urol, 1998, 8(5) ,312-317.
  • 9KIRBY RS, JENNY B, EARDLEY I, et al. Finasteride in the treatment of benign prostatic hyperplasia. A urodynamic evalua- tion[J]. Brit J Urol, 1992, 70(2):65-72.
  • 10KIRBY RS, VALE J, BRYAN J, et al. Long-term urodynamic effects of finasteride in benign prostatic hyperplasia : a pilot study [J]. Eur Urol, 1993, 24(1):20-26.

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部